Spyre Therapeutics, Inc. (SYRE) on Thursday reported a loss of $56.3 million in its fourth quarter. The Waltham, Massachusetts-based company said it had a loss of 81 cents per share. The results exceeded Wall Street expectations.

Veralto Corporation (VLTO), headquartered in Waltham, Massachusetts, offers water analytics, water treatment, marking and coding, and packaging and color services. Valued at $24.2 billion by market cap,

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Spyre Therapeutics, Inc. (SYRE) on Thursday reported a loss of $56.3 million in its fourth quarter. The Waltham, Massachusetts-based company said it had a loss of 81 cents per share.

Waltham, Massachusetts-based Revvity ... $138.24 represents a 20.5% premium to RVTY’s current price levels. The Street-high price target of $155 suggests an upside potential of 35.1%.

Veralto Corporation (VLTO), headquartered in Waltham, Massachusetts ... Its adjusted EPS of $0.95 surpassed Wall Street expectations of $0.88. The company’s revenue was $1.4 billion, topping ...